Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Promis Neurosciences Inc (PMN)

Promis Neurosciences Inc (PMN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Promis Neurosciences Inc SUITE 200 1920 YONGE STREET TORONTO A6 M4S 3E2 CAN

www.promisneurosciences.com Employees: 8 P: 416-847-6898 F: 415-847-6899

Sector:

Medical

Description:

ProMIS Neurosciences Inc. is a development stage biotechnology company. It focused on discovering and developing medicine therapeutics to treat neurodegenerative diseases in particular Alzheimer's disease and amyotrophic lateral sclerosis. The company's product portfolio includes PMN310, PMN350, PMN330, PMN110, PMN120 and PMN130 which are in its pre-clinical stage. ProMIS Neurosciences Inc.is headquartered in Toronto, Canada.

Key Statistics

Overview:

Market Capitalization, $K 17,551
Enterprise Value, $K 4,261
Shares Outstanding, K 2,152
Float, K 2,071
% Float 96.20%
Short Interest, K 35
Short Float 1.63%
Days to Cover 1.03
Short Volume Ratio 0.17
% of Insider Shareholders 3.80%
% of Institutional Shareholders 50.13%
Annual Net Income, $ 2,780 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -11,580 K
EBIT, $ -35,390 K
EBITDA, $ -35,370 K
3-Year Return -94.25%
5-Year Return -93.74%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 66.60%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -6.00 on 11/12/25
Next Earnings Date 03/30/26
Earnings Per Share ttm -19.00
EPS Growth vs. Prev Qtr 17.24%
EPS Growth vs. Prev Year -71.43%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-25 on 11/28/25

PMN Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -336.93%
Return-on-Assets % -184.39%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 1.91
Book Value/Share 4.27
Interest Coverage 35.75
60-Month Beta -0.10
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar